MAPT and Alzheimer disease: Third, because of the lack of beta amyloid or dopamine transporter imaging, beta amyloid or Tau measurement in cerebrospinal fluid, or post-mortem pathological evaluation, the diagnosis of AD was based on the clinical criteria for typical AD, which might have resulted in a lower diagnostic accuracy for AD.